Diagnostic Imaging of the Thyroid and Radioiodine Therapy

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gritzmann N, Koischwitz D, Rettenbacher T (2000) Sonography of the thyroid and parathyroid glands. Radiol Clin North Am 38:1131–1145PubMedCrossRefGoogle Scholar
  2. 2.
    Hegedus L (2001) Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339–360PubMedCrossRefGoogle Scholar
  3. 3.
    Solbiati L, Osti V, Cova L, Tonolini M (2001) Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol 11:2411–2424PubMedCrossRefGoogle Scholar
  4. 4.
    Baskin MD, Face HJ (1997) Thyroid ultrasonography: a review. Endocr Pract 3:153–157PubMedGoogle Scholar
  5. 5.
    Baldini M, Castagnone D, Rivolta D, et al (1997) Thyroid vascularisation by color Doppler ultrasonography in Graves disease. Changes related to different phases and to long-term outcome of the disease. Thyroid 7:823–828PubMedGoogle Scholar
  6. 6.
    Birchall IW, Chow CC, Metreweli C (1990) Ultrasound appearances of de Quervain’s thyroiditis. Clin Radiol 41:57–59PubMedCrossRefGoogle Scholar
  7. 7.
    Sostre S, Reyes MM (1991) Sonographic diagnosis and grading of Hashimoto’s thyroiditis. J Endocrinol Invest 14:115–121PubMedGoogle Scholar
  8. 8.
    Papi G, LiVolsi VA (2004) Current concepts on Riedel thyroiditis. Am J Clin Pathol 121(suppl):50–63Google Scholar
  9. 9.
    Kobayashi T, Naka W, Harada T, Nishikawa T (1995) Association of the acral type of pustular psoriasis, Sjogren’s syndrome, systemic lupus erythematosus, and Hashimoto’s thyroiditis. J Dermatol 22125–22128Google Scholar
  10. 10.
    Tutuncu NB, Erbas T, Bayraktar M, Gedik O (2000) Multifocal idiopathic fibrosclerosis manifesting with Riedel’s thyroiditis. Endocr Pract 6:447–449PubMedGoogle Scholar
  11. 11.
    Wiesner W, Engel H, von Schulthess GK, Krestin GP, Bicik I (1999) FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive Hürthle cell tumor of the thyroid. Eur Radiol 9:975–978PubMedCrossRefGoogle Scholar
  12. 12.
    Gertner ME, Kebebew E (2004) Multiple endocrine neoplasia type 2. Curr Treat Options Oncol 5:315–325PubMedGoogle Scholar
  13. 13.
    Michelow PM, Leiman G (1995) Metastases to the thyroid gland: diagnosis by aspiration cytology. Diagn Cytopathol 13:209–213PubMedGoogle Scholar
  14. 14.
    do Rosario PW, Fagundes TA, Maia FF, Franco AC, Figueiredo MB, Purisch S (2004) Sonography in the diagnosis of cervical recurrence in patients with differentiated thyroid carcinoma. J Ultrasound Med 23:915–920PubMedGoogle Scholar
  15. 15.
    Rodriguez JM, Reus M, Moreno A, Martinez M, Soria T, Carrasco L, Parrilla P (1997) High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer. Otolaryngol Head Neck Surg 117:694–697PubMedCrossRefGoogle Scholar
  16. 16.
    Simeone JF, Daniels GH, Hall DA, McCarthy K, Kopans DB, Butch RJ, Mueller PR, Stark DD, Ferrucci JT Jr, Wang CA (1987) Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 148:45–49PubMedGoogle Scholar
  17. 17.
    Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428PubMedCrossRefGoogle Scholar
  18. 18.
    DeGroot LJ, Kaplan EL, McCormick M, et al (1990) Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–424PubMedCrossRefGoogle Scholar
  19. 19.
    Wong JB, Kaplan MM, Meyer KB, et al (1990) Ablative radioiodine therapy for apparently localized thyroid carcinoma: a decision analytic perspective. Endocrinol Metab Clin North Am 19:741–760PubMedGoogle Scholar
  20. 20.
    Samaan NA, Schultz PN, Hickey RC, et al (1992) The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714–720PubMedCrossRefGoogle Scholar
  21. 21.
    Cooper DS, Specker B, Ho M, et al (1998) Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 8:737–744PubMedGoogle Scholar
  22. 22.
    Ross DS (1994) Hyperthyroidism, thyroid hormone therapy and bone. Thyroid 4:319–326PubMedCrossRefGoogle Scholar
  23. 23.
    Sawin CT, Geller A, Wolf PA, et al (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249–1252PubMedCrossRefGoogle Scholar
  24. 24.
    Biondi B, Fazio S, Carella C, et al (1994) Control of adrenergic overactivity by beta blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab 78:1028–1033PubMedCrossRefGoogle Scholar
  25. 25.
    Biermann M, Pixberg MK, Schuck A, Heinecke A, Kopcke W, Schmid KW, Dralle H, Willich N, Schober O (2003) Multicenter study differentiated thyroid carcinoma (MSDS). Diminished acceptance of adjuvant external beam radiotherapy. Nuklearmedizin 42:244–250PubMedGoogle Scholar
  26. 26.
    Brierley JD, Tsang RW (1996) External radiation therapy in the treatment of thyroid malignancy. Endocrinol Metab Clin North Am 25:141–157PubMedCrossRefGoogle Scholar
  27. 27.
    Van Tol KM, Jager PL, Piers DA, et al (2002) Better yield of 18fluorodeoxyglucose positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation. Thyroid 12:381–387PubMedCrossRefGoogle Scholar
  28. 28.
    Chin BB, Patel P, Cohade C, et al (2004) Recombinant human thyrotropin stimulation of fluoro-d-glucose positron emission tomography uptake in well differentiated thyroid carcinoma. J Clin Endocrinol Metab 89:91–95PubMedCrossRefGoogle Scholar
  29. 29.
    Grigsby PW, Baglan K, Siegel BA (1999) Surveillance of patients to detect recurrent thyroid carcinoma. Cancer 85:945–951PubMedCrossRefGoogle Scholar
  30. 30.
    Maxon HR, Smith HS (1990) Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 19:685–719PubMedGoogle Scholar
  31. 31.
    Beierwaltes WH (1978) The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 8:79–94PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Personalised recommendations